Literature DB >> 29404842

Cardiorespiratory fitness and adiposity in breast cancer survivors: is meeting current physical activity recommendations really enough?

Alejandro Santos-Lozano1,2, Javier Ramos3, Alejandro Alvarez-Bustos3, Blanca Cantos3, Lidia B Alejo1,4, Itziar Pagola1,4, Ana Soria5, Constanza Maximiano3, Carmen Fiuza-Luces1, Luisa Soares-Miranda6, Alejandro Lucia1,4, Ana Ruiz-Casado3.   

Abstract

PURPOSE: Breast cancer (BC) survivors are becoming increasingly predisposed to cardiovascular disease (CVD) mortality. Low cardiorespiratory fitness and physical activity (PA) levels, as well as high values of adiposity indices, contribute to CVD risk. We evaluated adiposity, cardiorespiratory profile, and PA levels in two independent cohorts of BC survivors.
METHODS: Data were collected from two groups (99% women) from different areas of Madrid (Spain): group 1, n = 110, age 51.4 ± 9.7 years, median time from diagnosis 365 days (95% confidence interval [CI], 354-401), and group 2, n = 93, age 54.7 ± 8.9 years, 1714 days (95% CI, 1502-1938). We estimated peak oxygen uptake (VO2peak) and measured body mass index (BMI), waist circumference (WC), waist-to-hip index, and accelerometry-determined PA.
RESULTS: Both groups had values of BMI in the overweight range (25.3 ± 4.3 and 27.1 ± 5.1 kg/m2, p = 0.003). Estimated VO2peak levels were lower in group 2 than in group 1 (28.1 ± 9.1 and 23.7 ± 8.8 ml/kg/min, p < 0.001), although levels in both groups were low. Yet, the majority of participants in both groups (81 and 88%, p = 0.234) met international PA recommendations (235 ± 196 and 351 ± 173 min/week of moderate-vigorous PA, p < 0.001). Both groups had very low levels of vigorous PA. These results were essentially independent of type of treatment (anthracycline/radiotherapy).
CONCLUSIONS: We found a poor cardiorespiratory profile in two independent BC cohorts that differed in median time from diagnosis (as well in socioeconomic status), supporting the notion that implementation of PA (possibly focusing on vigorous PA) and dietary intervention is urgently needed in this patient population.

Entities:  

Keywords:  Accelerometry; Anthracyclines; Moderate–vigorous physical activity; VO2peak

Mesh:

Year:  2018        PMID: 29404842     DOI: 10.1007/s00520-018-4055-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  48 in total

1.  Objectively assessed physical activity levels in Spanish cancer survivors.

Authors:  Ana Ruiz-Casado; Ana Soria Verdugo; María J Ortega Solano; Itziar Pagola Aldazabal; Carmen Fiuza-Luces; Lidia Brea Alejo; Julio R Padilla del Hierro; Isabel Palomo; Oscar Aguado-Arroyo; Nuria Garatachea; Héctor Cebolla; Alejandro Lucia
Journal:  Oncol Nurs Forum       Date:  2014-01-01       Impact factor: 2.172

2.  Primary prevention of cardiovascular disease with a Mediterranean diet.

Authors:  Ramón Estruch; Emilio Ros; Jordi Salas-Salvadó; Maria-Isabel Covas; Dolores Corella; Fernando Arós; Enrique Gómez-Gracia; Valentina Ruiz-Gutiérrez; Miquel Fiol; José Lapetra; Rosa Maria Lamuela-Raventos; Lluís Serra-Majem; Xavier Pintó; Josep Basora; Miguel Angel Muñoz; José V Sorlí; José Alfredo Martínez; Miguel Angel Martínez-González
Journal:  N Engl J Med       Date:  2013-02-25       Impact factor: 91.245

3.  Elite athletes live longer than the general population: a meta-analysis.

Authors:  Nuria Garatachea; Alejandro Santos-Lozano; Fabian Sanchis-Gomar; Carmen Fiuza-Luces; Helios Pareja-Galeano; Enzo Emanuele; Alejandro Lucia
Journal:  Mayo Clin Proc       Date:  2014-08-12       Impact factor: 7.616

4.  Cardiovascular disease and physical activity in adult cancer survivors: a nested, retrospective study from the Atlantic PATH cohort.

Authors:  Melanie R Keats; Yunsong Cui; Scott A Grandy; Louise Parker
Journal:  J Cancer Surviv       Date:  2016-11-16       Impact factor: 4.442

5.  Late cardiac effect of anthracycline therapy in physically active breast cancer survivors - a prospective study.

Authors:  A C Nagy; P GulAcsi-BArdos; Z CserEp; L Hangody; T Forster
Journal:  Neoplasma       Date:  2017       Impact factor: 2.575

6.  Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: A cross-sectional study.

Authors:  Liselotte M Boerman; Saskia W M C Maass; Peter van der Meer; Jourik A Gietema; John H Maduro; Yoran M Hummel; Marjolein Y Berger; Geertruida H de Bock; Annette J Berendsen
Journal:  Eur J Cancer       Date:  2017-06-08       Impact factor: 9.162

7.  Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Authors:  Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman
Journal:  Lancet       Date:  2014-11-26       Impact factor: 79.321

8.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

Review 9.  American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.

Authors:  Carolyn D Runowicz; Corinne R Leach; N Lynn Henry; Karen S Henry; Heather T Mackey; Rebecca L Cowens-Alvarado; Rachel S Cannady; Mandi L Pratt-Chapman; Stephen B Edge; Linda A Jacobs; Arti Hurria; Lawrence B Marks; Samuel J LaMonte; Ellen Warner; Gary H Lyman; Patricia A Ganz
Journal:  CA Cancer J Clin       Date:  2015-12-07       Impact factor: 508.702

10.  European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; W M Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte Op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Int J Behav Med       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.